For Immediate Release
FDA Authorizes and CDC Recommends Second Booster Dose of Two COVID-19 Vaccines for Older and Immunocompromised Individuals
March 31, 2022, Jackson, WY – The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) have updated their authorizations and recommendations to allow individuals over the age of 50 and certain immunocompromised individuals to receive a second COVID-19 mRNA vaccine booster dose. These groups are now eligible to get a second Pfizer or Moderna booster dose at least four months after their first booster (whether they received a Pfizer, Moderna, or Johnson & Johnson booster).
This action makes a second booster dose of these COVID-19 vaccines available to other populations at higher risk for severe disease, hospitalization, and death. Preventing infection also reduces the chances of developing long COVID. Emerging evidence suggests that a second booster dose of an mRNA COVID-19 vaccine improves protection against severe COVID-19 and is not associated with new safety concerns.
The FDA amended the emergency use authorizations as follows:
- Individuals 50+
- A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine or Moderna COVID-19 Vaccine may be administered to individuals 50 years of age and older at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine.
- Individuals Immunocompromised 12+
- A second booster dose of the Pfizer-BioNTech COVID-19 Vaccine may be administered to individuals 12 years of age and older with certain kinds of immunocompromised conditions at least 4 months after receipt of a first booster dose of any authorized or approved COVID-19 vaccine. These are people who have undergone solid organ transplantation, or who are living with conditions that are considered to have an equivalent level of immunocompromised status.
- Individuals Immunocompromised 18+
- A second booster dose of the Moderna COVID-19 Vaccine may be administered at least 4 months after the first booster dose of any authorized or approved COVID-19 vaccine to individuals 18 years of age and older with the same certain kinds of immunocompromised status.
Please visit the CDC website for a complete list of conditions that are considered to be moderately to severely immunocompromising.
Teton County Health Department will host a vaccination clinic by appointment, to accommodate those interested in receiving a COVID-19 vaccine on Thursday, April 7, from 9:00 am to 11:45 am, however the COVID-19 vaccine clinic will otherwise be closed from March 31 to April 11. The vaccine clinic is located at the Teton County Health Department, 460 East Pearl Avenue. Albertson’s Pharmacy is also offering COVID-19 booster doses for those eligible or check with your preferred provider.
To make an appointment for this clinic date, please visit https://hipaa.jotform.com/TCHD/covidvax or call the Call Center at 307-732-8628. Individuals, parents, and guardians should consult their health care provider or family physician for additional guidance or questions they have regarding any of the COVID-19 vaccines.
Data continues to show the importance of vaccination and booster doses to protect individuals both from infection and severe outcomes of COVID-19. To date, booster doses have been effective in boosting immunity against new variants of COVID-19 and extending protection of the vaccine against serious illness. We continue to emphasize that vaccination and getting boosted is one of the most important elements of mitigating serious illness, hospitalization, and death.